Clinical Trial Update: Fimasartan/Amlodipine Combination Phase III [Phase 3]

View source ↗

Summary

Phase III trial of the fixed-dose combination fimasartan/amlodipine for essential hypertension has completed (status COMPLETED). No efficacy or safety results a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fimasartan/amlodipine

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED